1.0
27 Feb 2023
Current employee, more than 8 years
Darmstadt
Recommend
CEO approval
Business outlook
Pros
Good Comp & Ben compared to other companies with relatively same size.
Cons
Toxic R&D environment, less than coordinated re-org/restructuring, reasoning does not resonate or make any sense. Medical Affairs and Clinical Development employees are second class citizens compared to commercial organization. The big R&D head is only concerned about his own self and his LT are worried about nothing but to maintain their SVPs entitlement